|
|
Volumn 21, Issue 9, 2006, Pages 2676-2677
|
|
Hyperphosphataemia and related mortality [12]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PHOSPHATE;
PHOSPHATE BINDING AGENT;
CLINICAL TRIAL;
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;
DIALYSATE;
DISEASE ASSOCIATION;
DISEASE CONTROL;
HEMODIALYSIS;
HEMOFILTRATION;
HUMAN;
HYPERPHOSPHATEMIA;
INTERMETHOD COMPARISON;
KIDNEY FAILURE;
LETTER;
LONG TERM CARE;
MORTALITY;
PHOSPHATE BLOOD LEVEL;
PHOSPHATE INTAKE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROTEIN DEFICIENCY;
PROTEIN DEPLETION;
PROTEIN DIET;
SHORT COURSE THERAPY;
BLOOD;
CHRONIC KIDNEY FAILURE;
COMPARATIVE STUDY;
DISORDERS OF MINERAL, ELECTROLYTE AND METAL METABOLISM;
NETHERLANDS;
NOTE;
RISK FACTOR;
SURVIVAL RATE;
HUMANS;
KIDNEY FAILURE, CHRONIC;
NETHERLANDS;
PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;
PHOSPHATES;
PHOSPHORUS METABOLISM DISORDERS;
RISK FACTORS;
SURVIVAL RATE;
|
|
EID: 33750092502
PISSN: 09310509
EISSN: 14602385
Source Type: Journal
DOI: 10.1093/ndt/gfl229 Document Type: Letter |
|
Times cited : (5)
|
|
References (5)
|
